A possible mechanism for prevention of intestinal programmed cell death after ischemia-reperfusion injury by hepatocyte growth factor pretreatment

Journal of Pediatric Surgery

Volumn 37, Issue 12, 2002, Pages 1696-1699

  Kuenzler, Keith A ^a,b   Arthur, L Grier ^a,b   Schwartz, Marshall Z ^a,b  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Apoptosis; Caspase 3; Caspase 8; Hepatocyte growth factor; Intestinal ischemia; Ischemia reperfusion injury

Indexed keywords

CASPASE 3; CASPASE 8; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CELL DEATH; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; DNA DEGRADATION; INTESTINE CELL; INTESTINE ISCHEMIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0036895778     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2002.36698     Document Type: Conference Paper

References (11)

1. Shah KA, Shurey S, Green CJ: Apoptosis after intestinal ischemia-reperfusion injury. Transplantation 64:1393-1397, 1997
2. Noda T, Iwakiri R, Fujimoto K, et al: Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa. Am J Physiol 274:G270-276, 1998
3. Cohen GM: Caspases: The executioners of apoptosis. Biochem J 326:1-16, 1997
4. Kuenzler KA, Pearson PY, Schwartz MZ: Hepatocyte growth factor pretreatment reduces apoptosis and mucosal damage following intestinal ischemia-reperfusion. J Pediatr Surg 37:1093-1097, 2002
5. 2+ associated with apoptosis in Schwartz LM, Osbourne B (eds): Methods in Cell Biology. San Diego, CA, Academic Press, 1995, pp 41-55
6. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462, 1995
7. Michalsky MP, Kuhn A, Mehta V, et al: Heparin-binding EGF-like growth factor decreases apoptosis in intestinal epithelial cells in vitro. J Pediatr Surg 36:1130-1135, 2001
8. Lieberthal W, Triaca V, Koh JS, et al: Role of superoxide in apoptosis induced by growth factor withdrawal. J Physiol (Lond) 275:F691-F702, 1998
9. Kato Y, Yu D, Schwartz MZ: Enhancement of intestinal adaptation by hepatocyte growth factor. J Pediatr Surg 33:235-239, 1998
10. Kato Y, Yu D, Lukish JR, et al: Hepatocyte growth factor enhances intestinal mucosal cell function and mass in vivo. J Pediatr Surg 32:991-994, 1997
11. Saikumar P, Dong Z, Weinberg JM, et al: Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 17:3341-3349, 1998